Výsledky vyhledávání

Akademický článek

Same-day testing with initiation of antiretroviral therapy or tuberculosis treatment versus standard care for persons presenting with tuberculosis symptoms at HIV diagnosis: A randomized open-label trial from Haiti.

Autor: Dorvil N; Haitian Group for the Study of Kaposi's Sarcoma and Opportunistic Infections (GHESKIO), Port-au-Prince, Haiti., Rivera VR; Haitian Group for the Study of Kaposi's Sarcoma and Opportunistic Infections (GHESKIO), Port-au-Prince, Haiti., Riviere C; Haitian Group for the Study of Kaposi's Sarcoma and Opportunistic Infections (GHESKIO), Port-au-Prince, Haiti., Berman R; The Analysis Group, Boston, Massachusetts, United States of America., Severe P; Haitian Group for the Study of Kaposi's Sarcoma and Opportunistic Infections (GHESKIO), Port-au-Prince, Haiti., Bang H; University of California, Davis School of Medicine, Davis, California, United States of America., Lavoile K; Haitian Group for the Study of Kaposi's Sarcoma and Opportunistic Infections (GHESKIO), Port-au-Prince, Haiti., Devieux JG; Florida International University, Miami, Florida, United States of America., Faustin M; Haitian Group for the Study of Kaposi's Sarcoma and Opportunistic Infections (GHESKIO), Port-au-Prince, Haiti., Saintyl G; Haitian Group for the Study of Kaposi's Sarcoma and Opportunistic Infections (GHESKIO), Port-au-Prince, Haiti., Mendicuti MD; Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, United States of America., Pierre S; Haitian Group for the Study of Kaposi's Sarcoma and Opportunistic Infections (GHESKIO), Port-au-Prince, Haiti., Apollon A; Haitian Group for the Study of Kaposi's Sarcoma and Opportunistic Infections (GHESKIO), Port-au-Prince, Haiti., Dumond E; Haitian Group for the Study of Kaposi's Sarcoma and Opportunistic Infections (GHESKIO), Port-au-Prince, Haiti., Forestal GPL; Haitian Group for the Study of Kaposi's Sarcoma and Opportunistic Infections (GHESKIO), Port-au-Prince, Haiti., Rouzier V; Haitian Group for the Study of Kaposi's Sarcoma and Opportunistic Infections (GHESKIO), Port-au-Prince, Haiti.; Weill Cornell Medicine, New York, New York, United States of America., Marcelin A; Haitian Group for the Study of Kaposi's Sarcoma and Opportunistic Infections (GHESKIO), Port-au-Prince, Haiti., McNairy ML; Weill Cornell Medicine, New York, New York, United States of America., Walsh KF; Weill Cornell Medicine, New York, New York, United States of America., Dupnik K; Weill Cornell Medicine, New York, New York, United States of America., Reif LK; Weill Cornell Medicine, New York, New York, United States of America., Byrne AL; St. Vincent's Hospital, Darlinghurst, New South Wales, Australia., Bousleiman S; The Analysis Group, Boston, Massachusetts, United States of America., Orvis E; The Analysis Group, Boston, Massachusetts, United States of America., Joseph P; Haitian Group for the Study of Kaposi's Sarcoma and Opportunistic Infections (GHESKIO), Port-au-Prince, Haiti., Cremieux PY; The Analysis Group, Boston, Massachusetts, United States of America., Pape JW; Haitian Group for the Study of Kaposi's Sarcoma and Opportunistic Infections (GHESKIO), Port-au-Prince, Haiti.; Weill Cornell Medicine, New York, New York, United States of America., Koenig SP; Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, United States of America.

Publikováno v: PLoS medicine [PLoS Med] 2023 Jun 09; Vol. 20 (6), pp. e1004246. Date of Electronic Publication: 2023 Jun 09 (Print Publication: 2023).

Zobrazit plný text záznamu

Plný text ve formátu HTML

Akademický článek

FAST tuberculosis transmission control strategy speeds the start of tuberculosis treatment at a general hospital in Lima, Peru.

Autor: Tierney DB; Brigham and Women's Hospital, Boston, Massachusetts, United States.; Harvard Medical School, Boston, Massachusetts, United States., Orvis E; Analysis Group, Boston, Massachusetts, United States., Nathavitharana RR; Harvard Medical School, Boston, Massachusetts, United States.; Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States., Hurwitz S; Brigham and Women's Hospital, Boston, Massachusetts, United States.; Harvard Medical School, Boston, Massachusetts, United States., Tintaya K; Socios En Salud Sucursal Peru, Lima, Peru., Vargas D; Hospital Nacional Hipolito Unanue, Lima, Peru., Segura P; Hospital Nacional Hipolito Unanue, Lima, Peru., de la Gala S; Socios En Salud Sucursal Peru, Lima, Peru., Lecca L; Socios En Salud Sucursal Peru, Lima, Peru., Mitnick CD; Brigham and Women's Hospital, Boston, Massachusetts, United States.; Department of Global Health and Social Medicine, Harvard Medical School, Boston, Massachusetts, United States., Nardell EA; Brigham and Women's Hospital, Boston, Massachusetts, United States.; Harvard Medical School, Boston, Massachusetts, United States.

Publikováno v: Infection control and hospital epidemiology [Infect Control Hosp Epidemiol] 2022 Oct; Vol. 43 (10), pp. 1459-1465. Date of Electronic Publication: 2021 Oct 06.

Zobrazit plný text záznamu

Akademický článek

Economic Benefit from Improvements in Quality of Life with Upadacitinib: Comparisons with Tofacitinib and Methotrexate in Patients with Rheumatoid Arthritis.

Autor: Bergman M; Drexel University College of Medicine, Philadelphia, PA, USA., Tundia N; AbbVie Inc., North Chicago, IL, USA., Yang M; Analysis Group, Inc., 111 Huntington Avenue 14th Floor, Boston, MA, 02199, USA., Orvis E; Analysis Group, Inc., 111 Huntington Avenue 14th Floor, Boston, MA, 02199, USA., Clewell J; AbbVie Inc., North Chicago, IL, USA., Bensimon A; Analysis Group, Inc., 111 Huntington Avenue 14th Floor, Boston, MA, 02199, USA. Arielle.Bensimon@analysisgroup.com.

Publikováno v: Advances in therapy [Adv Ther] 2021 Dec; Vol. 38 (12), pp. 5649-5661. Date of Electronic Publication: 2021 Oct 12.

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání